Condition
Aortitis
Total Trials
5
Recruiting
3
Active
3
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Recruiting3
Completed2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT02967068RecruitingPrimary
VCRC Tissue Repository
NCT06866535RecruitingPrimary
VIP - Vascular Infection Project
NCT06271018RecruitingPrimary
TocILizumab in aorTitis in GCA (TILT)
NCT03022331CompletedPrimary
VCRC Longitudinal Protocol for Aortitis
NCT01795456Completed
Carotid Artery Neovascularization in Takayasu's and Giant Cell Arteritis
Showing all 5 trials